169 related articles for article (PubMed ID: 19244545)
1. Dependence on nuclear localization signals of the opioid growth factor receptor in the regulation of cell proliferation.
Cheng F; McLaughlin PJ; Verderame MF; Zagon IS
Exp Biol Med (Maywood); 2009 May; 234(5):532-41. PubMed ID: 19244545
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cell proliferation by the opioid growth factor receptor is dependent on karyopherin beta and Ran for nucleocytoplasmic trafficking.
Cheng F; McLaughlin PJ; Zagon IS
Exp Biol Med (Maywood); 2010 Sep; 235(9):1093-101. PubMed ID: 20705629
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cell proliferation by the OGF-OGFr axis is dependent on nuclear localization signals.
Exp Biol Med (Maywood); 2009 May; 234(5):vi. PubMed ID: 19395689
[No Abstract] [Full Text] [Related]
4. Nucleocytoplasmic distribution of opioid growth factor and its receptor in tongue epithelium.
Zagon IS; Ruth TB; McLaughlin PJ
Anat Rec A Discov Mol Cell Evol Biol; 2005 Jan; 282(1):24-37. PubMed ID: 15584033
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells.
Zagon IS; Verderame MF; Hankins J; McLaughlin PJ
Int J Oncol; 2007 Apr; 30(4):775-83. PubMed ID: 17332915
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the opioid growth factor receptor downregulates cell proliferation of human squamous carcinoma cells of the head and neck.
McLaughlin PJ; Verderame MF; Hankins JL; Zagon IS
Int J Mol Med; 2007 Mar; 19(3):421-8. PubMed ID: 17273790
[TBL] [Abstract][Full Text] [Related]
7. Progression of squamous cell carcinoma of the head and neck is associated with down-regulation of the opioid growth factor receptor.
McLaughlin PJ; Zagon IS
Int J Oncol; 2006 Jun; 28(6):1577-83. PubMed ID: 16685459
[TBL] [Abstract][Full Text] [Related]
8. Subcellular trafficking signals of constitutive androstane receptor: evidence for a nuclear export signal in the DNA-binding domain.
Xia J; Kemper B
Drug Metab Dispos; 2007 Sep; 35(9):1489-94. PubMed ID: 17567731
[TBL] [Abstract][Full Text] [Related]
9. Opioid growth factor receptor is unaltered with the progression of human pancreatic and colon cancers.
Zagon IS; McLaughlin PJ
Int J Oncol; 2006 Aug; 29(2):489-94. PubMed ID: 16820893
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the opioid growth factor receptor in human cancers alter receptor function.
Kren NP; Zagon IS; McLaughlin PJ
Int J Mol Med; 2015 Jul; 36(1):289-93. PubMed ID: 26005722
[TBL] [Abstract][Full Text] [Related]
11. Featured Article: Nuclear export of opioid growth factor receptor is CRM1 dependent.
Kren NP; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Feb; 241(3):273-81. PubMed ID: 26429201
[TBL] [Abstract][Full Text] [Related]
12. Prevention and delay in progression of human squamous cell carcinoma of the head and neck in nude mice by stable overexpression of the opioid growth factor receptor.
McLaughlin PJ; Kreiner S; Morgan CR; Zagon IS
Int J Oncol; 2008 Oct; 33(4):751-7. PubMed ID: 18813788
[TBL] [Abstract][Full Text] [Related]
13. Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea.
Zagon IS; Ruth TB; Leure-duPree AE; Sassani JW; McLaughlin PJ
Brain Res; 2003 Mar; 967(1-2):37-47. PubMed ID: 12650964
[TBL] [Abstract][Full Text] [Related]
14. T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.
Zagon IS; Donahue RN; Bonneau RH; McLaughlin PJ
Immunobiology; 2011 May; 216(5):579-90. PubMed ID: 20965606
[TBL] [Abstract][Full Text] [Related]
15. Defects in the opioid growth factor receptor in human squamous cell carcinoma of the head and neck.
McLaughlin PJ; Stack BC; Levin RJ; Fedok F; Zagon IS
Cancer; 2003 Apr; 97(7):1701-10. PubMed ID: 12655527
[TBL] [Abstract][Full Text] [Related]
16. Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor.
Zagon IS; Kreiner S; Heslop JJ; Conway AB; Morgan CR; McLaughlin PJ
Int J Oncol; 2008 Aug; 33(2):317-23. PubMed ID: 18636152
[TBL] [Abstract][Full Text] [Related]
17. Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer.
Zagon IS; Porterfield NK; McLaughlin PJ
Exp Biol Med (Maywood); 2013 Jun; 238(6):589-99. PubMed ID: 23918871
[TBL] [Abstract][Full Text] [Related]
18. Expression of the opioid growth factor-opioid growth factor receptor axis in human ovarian cancer.
Fanning J; Hossler CA; Kesterson JP; Donahue RN; McLaughlin PJ; Zagon IS
Gynecol Oncol; 2012 Feb; 124(2):319-24. PubMed ID: 22037317
[TBL] [Abstract][Full Text] [Related]
19. B lymphocyte proliferation is suppressed by the opioid growth factor-opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases.
Zagon IS; Donahue RN; Bonneau RH; McLaughlin PJ
Immunobiology; 2011; 216(1-2):173-83. PubMed ID: 20598772
[TBL] [Abstract][Full Text] [Related]
20. Nuclear import of HSV-1 DNA polymerase processivity factor UL42 is mediated by a C-terminally located bipartite nuclear localization signal.
Alvisi G; Avanzi S; Musiani D; Camozzi D; Leoni V; Ly-Huynh JD; Ripalti A
Biochemistry; 2008 Dec; 47(52):13764-77. PubMed ID: 19053255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
